| Exhibit 23.1 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237736 and No. 333-264394) and on Form S-8 (No. 333-148983, No. 333-182677, No. 333-203960, No. 333-225526, No. 333-239101, No. 333-266131 and No. 333-273396) of Protalix BioTherapeutics, Inc. of our report dated March 14, 2024 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel March 14, 2024 | /s/ Kesselman & Kesselman Certified Public Accountants (lsr.) A member firm of PricewaterhouseCoopers International Limited |
| |